short term prednisolon in itp

Phase 3

• Conditions: Treatment Patients with acute immune thrombocytopenia.; Immune thrombocytopenic purpura; D69.3

• Registration Number: IRCT20230718058831N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

childeren with acuteImmune Thrombocytopenia

Exclusion Criteria

Patients with active infections and septicemia
patients with positive antinuclear antibody
patients with Evans syndrome
Patients with chronic immune thrombocytopenia
Patients with positive glue culture

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Platelet count of patients after a short course of prednisolone. Timepoint: Comment on the number of blood platelets at different time points before the start and days 2, 7, 30 and 60 after the start of the treatment period. Method of measurement: Compelete blood count.